Last reviewed · How we verify
ChAd155-RG
At a glance
| Generic name | ChAd155-RG |
|---|---|
| Sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
- Vaccination site pain
- Headache
- Fatigue
- Malaise
- Feeling of body temperature change
- White blood cell count decreased
- Myalgia
- Nausea
- Arthralgia
- Vaccination site erythema
- Neutrophil count decreased
- Pyrexia
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |